Genvec Inc (GNVC) financial statements (2021 and earlier)

Company profile

Business Address 910 CLOPPER ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments478515
Cash and cash equivalents47854
Short-term investments    11
Receivables00001
Prepaid expense and other current assets0
Other undisclosed current assets4271 
Total current assets:7915716
Noncurrent Assets
Property, plant and equipment00011
Restricted cash and investments   0 
Other noncurrent assets000 
Prepaid expense and other noncurrent assets0
Total noncurrent assets:00011
TOTAL ASSETS:8916717
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22223
Accounts payable11112
Accrued liabilities000  
Employee-related liabilities10111
Deferred revenue and credits    0
Other undisclosed current liabilities   11
Total current liabilities:22234
Noncurrent Liabilities
Liabilities, other than long-term debt000  
Other liabilities000  
Other undisclosed noncurrent liabilities1    
Total noncurrent liabilities:100  
Total liabilities:32234
Stockholders' equity
Stockholders' equity attributable to parent5813514
Common stock00000
Additional paid in capital295293292280280
Accumulated other comprehensive loss(0)(0)(0)(0)(0)
Accumulated deficit(291)(285)(278)(276)(266)
Total stockholders' equity:5813514
TOTAL LIABILITIES AND EQUITY:8916717

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net116  
Gross profit:11649
Operating expenses(8)(7)(9)(14)(23)
Operating loss:(7)(7)(3)(10)(14)
Nonoperating income1   0
Net loss:(6)(7)(3)(10)(14)
Other undisclosed net income attributable to parent 000 
Net loss available to common stockholders, diluted:(6)(7)(3)(10)(14)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss:(6)(7)(3)(10)(14)
Comprehensive loss:(6)(7)(3)(10)(14)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0000(0)
Comprehensive loss, net of tax, attributable to parent:(6)(7)(3)(10)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: